The Cannon Catheter-A Prospective Analysis.

Caridi J, Ross E, Aspilcueta A, Wiley S.
J Vasc Interv Radiol. 2010 Aug 27.

Prosthetic lower extremity hemodialysis access grafts have satisfactory patency despite a high incidence of infection.

J. Vasc Surg. 2010 Aug 21.

Geenen IL, Nyilas L, Stephen MS, Makeham V, White GH, Verran DJ.
Transplantation and Vascular Surgical Services, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia; General Surgery, Maastricht University Medical Centre, Maastricht, Maastricht, The Netherlands.

Automated Intravascular Access Pressure Surveillance Reduces Thrombosis Rates.

Semin Dial. 2010 Aug 13.

Zasuwa G, Frinak S, Besarab A, Peterson E, Yee J.
Division of Nephrology and Hypertension, Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan.

Arteriovenous Fistulas among Incident Hemodialysis Patients in Department of Defense and Veterans Affairs Facilities.

J Am Soc Nephrol. 2010 Aug 12.

Hurst FP, Abbott KC, Raj D, Krishnan M, Palant CE, Agodoa LY, Jindal RM.

Geographic Concentration of Poverty and Arteriovenous Fistula Use among ESRD Patients.

J Am Soc Nephrol. 2010 Aug 5.
McClellan WM, et al

Vascular access using the superficial femoral vein.

Scollay JM, et al On Behalf of the East of Scotland Vascular Network.
J Vasc Access. 2010 Aug 3.
Department of Vascular Surgery, Ninewells Hospital and Medical School, Dundee - UK.

Antibiotic lock solutions for the prevention of catheter-related bacteraemia in haemodialysis patients.

Hong Kong Med J. 2010 Aug;16(4):269-74.
Chow KM,
Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong.

Conversion of Tunneled Hemodialysis Catheter into HeRO Device Can Provide Immediate Access for Hemodialysis.

Vasquez JC, et al
Vasc Endovascular Surg. 2010 Jul 30.

Clinical outcome of overlapping stents in hemodialysis access.

J Vasc Access. 2010 Jul 21.
Chan MR, Yevzlin AS.
Division of Nephrology, Department of Medicine, University of Wisconsin, Madison, W

Hemodialysis vascular access ultrasonography: tips, tricks, pitfalls and a quiz.

J Vasc Access. 2010 Jul 20.
Van Hooland S, Malik J.
Department of Nephrology, AZ St Lucas, Ghent - Belgium.

Outpatient surgeries of patients with arteriovenous fistulas for hemodialysis. Integrated activity in a general surgery unit.

Nefrologia. 2010;30(4):452-457 [Article in Spanish, English]
Jiménez-Almonacid P, et al

Vascular changes at the puncture segments of arteriovenous fistula for hemodialysis access.

J Vasc Surg. 2010 Jul 8.

Hsiao JF,
Cardiovascular Division, Department of Internal Medicine
Chia-Yi Chang Gung Memorial Hospital.

Patients' Perspectives of Constant-Site (Buttonhole) Cannulation for Haemodialysis Access.

Nephron Clin Pract. 2010 May 21;116(2):c123-c127.
Ward J, Shaw K,  Davenport A.
Barnet Dialysis Centre, Royal Free Hospital, London, UK.

Epidemiology, Surveillance, and Prevention of Bloodstream Infections in Hemodialysis Patients.
Am J Kidney Dis. 2010 Jun 14.
Patel PR et al
National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.

Fistula First: myth vs. fact.
Nephrol News Issues. 2010 Apr;24(4):36, 39-41.
Wish JB.

Vascular access for hemodialysis and cardiovascular complications.
Minerva Urol Nefrol. 2010 Mar;62(1):81-5.
Santoro D, et al

Long-term performance of the hemodialysis reliable outflow (HeRO) device: the 56-month follow-up of the first clinical trial patient.
Semin Dial. 2010 Mar;23(2):229-32.

Statin Therapy Is Not Associated with Improved Vascular Access Outcomes
Clin J Am Soc Nephrol. 2010 May 27.
Pisoni R, Barker-Finkel J, Allon M.

Buttonhole cannulation in hemodialysis: improved outcomes and increased expense--is it worth it?
CANNT J. 2010 Jan-Mar;20(1):29-37.
Ludlow V.
Patient Research Centre, Memorial University, St. John's, Newfoundland. vludlow@nl.rogers.com

Status of research in vascular access for dialysis.
Nephrol Dial Transplant. 2010 May 19.
Kian K, Asif A.
Denver Nephrology, 950 E Harvard Ave, Ste 240 Denver, CO, USA.

Early vascular access blood flow as a predictor of long-term vascular access patency in incident hemodialysis patients.

J Korean Med Sci. 2010 May;25(5):728-33.
Kim HS, Park JW, et al
Department of Internal Medicine, Gachon University of Medicine and Science, Incheon, Korea.

Vascular access for hemodialysis and cardiovascular complications.

Minerva Urol Nefrol. 2010 Mar;62(1):81-5.
Santoro D, Savica V, Bellinghieri G.
Unit of Nephrology and Dialysis, University of Messina, Messina, Italy - santisi@hotmail.com.

Is it possible to create a "mechanical" arteriovenous fistula in hemodialysis patients?

Artificial Organs. 2010 Mar;34(3):239-41.
Lo Monte AI, Buscemi G.
General Surgery and Organ Transplantation, University of Palermo, School of Medicine, Palermo, Italy. ailomonte@unipa.it

Vascular access for hemodialysis: Thrills and thrombosis.
J Vasc Nurs. 2010 Jun;28(2):78-83.
Gilpin V, Nichols WK.

Association of serum pentosidine with arterial stiffness in hemodialysis patients.
Artificial Organs. 2010 Mar;34(3):193-9.
Zhou Y, Yu Z, Jia H, Sun F, Ma L, Guo R, Peng L, Cui T.
Department of Nephrology, ChaoYang Hospital, Capital Medical University, Beijing, China.

Automated Intravascular Access Pressure Surveillance Reduces Thrombosis Rates.

Semin Dial. 2010 Aug 13.

Zasuwa G, Frinak S, Besarab A, Peterson E, Yee J.
Division of Nephrology and Hypertension, Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan.
Although monitoring of vascular accesses by physical examination is nearly as sensitive as surveillance measurements by vascular access pressure when performed by examiners, the frequency of examinations is limited by time.

We developed intravascular access pressure surveillance as a surrogate to physical examination. Using real-time data from hemodialysis machines, we derived intravascular access pressure ratios for each dialytic procedure. An automated, noninvasive surveillance algorithm that generated a "warning" list of patients at risk for thrombosis was formulated.

We hypothesized that this algorithm would reduce access thrombosis frequency. We designed a study comparing thrombosis rates during a baseline 6-month interval to three subsequent 6-month periods of active surveillance.

Referrals for interventions during this 18-month period were based on persistently abnormal elevated vascular access pressure ratio tests (VAPRT) >0.55.
Thrombosis rates declined progressively for arteriovenous grafts (AVG) during the intervention period compared with the baseline period.

Arteriovenous fistula (AVF) thrombosis rates decreased during postintervention months 13-18 during employment of the VAPRT.

We conclude that use of VAPRT can reduce thrombosis rates in vascular accesses, and the magnitude of the effect is larger and more consistent in arteriovenous grafts (AVGs) than autologous AVFs.